Efficacy and Safety of OROS Oybutynin and TTS Oxybutynin in Middle-Aged and Elderly Women With Urinary Incontinence
Status:
Completed
Trial end date:
1996-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the side-effect profile and efficacy of sustained
release, OROS® and TTS, dosage forms of oxybutynin with immediate release (IR) oral
oxybutynin and with placebo.